Hydrogen peroxide (H2O2), one of the most
stable and abundant reactive oxygen species (ROS), acting as a modulator
of dopaminergic signaling, has been intimately implicated in Parkinson’s
disease, creating a critical need for the selective quantification
of H2O2 in the living brain. Current natural
or nanomimic enzyme-based electrochemical methods employed for the
determination of H2O2 suffer from inadequate
selectivity and stability, due to which the in vivo measurement of H2O2 in the living brain remains
a challenge. Herein, a series of 5-(1,2-dithiolan-3-yl)-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pentanamide
(DBP) derivatives were designed by tuning the substitute groups and
sites of a boric acid ester, which served as probes to specifically
react with H2O2. Consequently, the reaction
products, 5-(1,2-dithiolan-3-yl)-N-(4-hydroxyphen-yl)pentanamide
(DHP) derivatives, converted the electrochemical signal from inactive
into active. After systematically evaluating their performances, 5-(1,2-dithiolan-3-yl)-N-(3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pentanamide
(o-Cl-DBP) was finally identified as the optimized
probe for H2O2 detection as it revealed the
fastest reaction time, the largest current density, and the most negative
potential. In addition, electrochemically oxidized graphene oxide
(EOGO) was utilized to produce a stable inner reference. The designed
electrochemical microsensor provided a ratiometric strategy for real-time
tracking of H2O2 in a linear range of 0.5–600
μM with high selectivity and accuracy. Eventually, the efficient
electrochemical microsensor was successfully applied to the measurement
of H2O2 in Parkinson’s disease (PD) mouse
brain. The average levels of H2O2 in the cortex,
striatum, and hippocampus in the normal mouse and PD mouse were systematically
compared for the first time.